LA JOLLA PHARMACEUTICAL CO·4

May 20, 5:17 PM ET

LA JOLLA PHARMACEUTICAL CO 4

4 · LA JOLLA PHARMACEUTICAL CO · Filed May 20, 2005

Insider Transaction Report

Form 4
Period: 2005-05-19
JENN PAUL
VP of Product Development
Transactions
  • Award

    Stock Option (right to buy)

    2005-05-19$0.43/sh+27,080$11,644489,474 total
    Exercise: $0.00Exp: 2015-05-19Common Stock (27,080 underlying)
Holdings
  • Common Stock

    3,302
Footnotes (1)
  • [F1]The stock options vest and become exercisable monthly over the next three years. In the event employee is terminated without cause or there is a change in control of the Company and employee's employment is terminated in connection with such change in control, the options automatically vest as of the date of employee's termination and remain exercisable for a period of one year following the date of termination.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_86505

    POA DOCUMENT